Progress in eliminating onchocerciasis in the WHO Region of the Americas: Advances in reaching the last endemic communities of the South Focus in the Bolivarian Republic of Venezuela
Ivermectin treatment and impact on the Yanomami Focus Area in 2021
In 2021, the COVID-19 pandemic continued to affect administrative processes and resources for MDA in both the Brazil Amazonas Focus and the Venezuela South Focus. Amazonas failed to reach its semiannual treatment goal in both rounds in 2021 (72% of its eligible population during the first and 64% during the second), and the South Focus failed in the first treatment round (47%) but succeeded in the second (88%).
Update to the WHO’s Weekly Epidemiological Record recording the progress made in the Americas toward elimination of onchocerciasis. WHO, September 30, 2022.